Excited and grateful that we received $500K from an angel investor, enabling us to move forward with our CLIA LDT certification and prototype testing for CAL, a first-in-class precision cancer diagnostic instrument.
cmargain
top of page
EMPIRI INC.
Search
Recent Posts
See AllJoin us at this month's virtual seminar as our co-founder Kyuson Yun, PhD will present "E-slice: TME-intact 3D culture platform for...
We are excited to share that Kyuson Yun, co-founder of Empiri, will be presenting at the 10x Genomics User Group Meeting. This is a...
EMPIRI's E-slice 3D tumor culture platform for real-time evaluation of therapeutic candidates can now be accessed through our store-front...
bottom of page
Comments